000 01471 a2200373 4500
005 20250513083630.0
264 0 _c19960206
008 199602s 0 0 eng d
022 _a0305-7453
024 7 _a10.1093/jac/36.1.109
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSt-Germain, G
245 0 0 _aKetoconazole and itraconazole susceptibility of Candida albicans isolated from patients infected with HIV.
_h[electronic resource]
260 _bThe Journal of antimicrobial chemotherapy
_cJul 1995
300 _a109-18 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAIDS-Related Opportunistic Infections
_xdrug therapy
650 0 4 _aAntifungal Agents
_xtherapeutic use
650 0 4 _aCandida albicans
_xdrug effects
650 0 4 _aCandidiasis, Oral
_xdrug therapy
650 0 4 _aDouble-Blind Method
650 0 4 _aHumans
650 0 4 _aItraconazole
_xtherapeutic use
650 0 4 _aKetoconazole
_xtherapeutic use
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aPredictive Value of Tests
650 0 4 _aProspective Studies
700 1 _aDion, C
700 1 _aEspinel-Ingroff, A
700 1 _aRatelle, J
700 1 _ade Repentigny, L
773 0 _tThe Journal of antimicrobial chemotherapy
_gvol. 36
_gno. 1
_gp. 109-18
856 4 0 _uhttps://doi.org/10.1093/jac/36.1.109
_zAvailable from publisher's website
999 _c8536357
_d8536357